N-(tert-Butoxycarbonal)-phenylalanyl-histidyl-(4-amino-3-hydroxy-5-cyc lohexyl)-pentacarbonyl-isoleucyl-(2-amidomethyl)tetrazol

Request For Quotation
N-(tert-Butoxycarbonal)-phenylalanyl-histidyl-(4-amino-3-hydroxy-5-cyc lohexyl)-pentacarbonyl-isoleucyl-(2-amidomethyl)tetrazol Suppliers list
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
N-(tert-Butoxycarbonal)-phenylalanyl-histidyl-(4-amino-3-hydroxy-5-cyc lohexyl)-pentacarbonyl-isoleucyl-(2-amidomethyl)tetrazol Basic information
Product Name:N-(tert-Butoxycarbonal)-phenylalanyl-histidyl-(4-amino-3-hydroxy-5-cyc lohexyl)-pentacarbonyl-isoleucyl-(2-amidomethyl)tetrazol
Synonyms:N-(tert-Butoxycarbonal)-phenylalanyl-histidyl-(4-amino-3-hydroxy-5-cyc lohexyl)-pentacarbonyl-isoleucyl-(2-amidomethyl)tetrazol;EMD 52297;L-threo-Pentonamide, 5-cyclohexyl-2,4,5-trideoxy-4-[[N-[N-[(1,1-dimethylethoxy)carbonyl]-L-phenylalanyl]-L-histidyl]amino]-N-[2-methyl-1-[[(2H-tetrazol-2-ylmethyl)amino]carbonyl]butyl]-, [S-(R*,R*)]- (9CI)
CAS:129049-51-0
MF:C39H59N11O7
MW:793.96
EINECS:
Product Categories:
Mol File:129049-51-0.mol
N-(tert-Butoxycarbonal)-phenylalanyl-histidyl-(4-amino-3-hydroxy-5-cyc lohexyl)-pentacarbonyl-isoleucyl-(2-amidomethyl)tetrazol Structure
N-(tert-Butoxycarbonal)-phenylalanyl-histidyl-(4-amino-3-hydroxy-5-cyc lohexyl)-pentacarbonyl-isoleucyl-(2-amidomethyl)tetrazol Chemical Properties
Safety Information
MSDS Information
N-(tert-Butoxycarbonal)-phenylalanyl-histidyl-(4-amino-3-hydroxy-5-cyc lohexyl)-pentacarbonyl-isoleucyl-(2-amidomethyl)tetrazol Usage And Synthesis
DescriptionEmd 52297 is a renin inhibitor.
UsesEMD 52297 is a Renin inhibitor, with acute hemodynamic and hormonal effects. EMD 52297 also acts as an ACE inhibitor[1][2].
References[1] Miriam T Rademaker, et al. Hemodynamic, hormonal, and renal effects of (pro)renin receptor blockade in experimental heart failure. Circ Heart Fail. 2012 Sep 1;5(5):645-52. DOI:10.1161/CIRCHEARTFAILURE.112.967059
[2] Jürgen Maibaum, et al. Renin inhibitors as novel treatments for cardiovascular disease. Expert Opinion on Therapeutic Patents. Volume 13, 2003 - Issue 5.
N-(tert-Butoxycarbonal)-phenylalanyl-histidyl-(4-amino-3-hydroxy-5-cyc lohexyl)-pentacarbonyl-isoleucyl-(2-amidomethyl)tetrazol Preparation Products And Raw materials
Tag:N-(tert-Butoxycarbonal)-phenylalanyl-histidyl-(4-amino-3-hydroxy-5-cyc lohexyl)-pentacarbonyl-isoleucyl-(2-amidomethyl)tetrazol(129049-51-0) Related Product Information
Carbamic acid, N-[2-[(R)-(3-chlorophenyl)[(3R)-1-[[[(2S)-2-(methylamino)-3-[(3R)-tetrahydro-2H-pyran-3-yl]propyl]amino]carbonyl]-3-piperidinyl]methoxy]ethyl]-, methyl ester, 2,2,2-trifluoroacetate (1:1) SODIUM NEW HOUTTUYFONATE A 65317 Aliskiren hemifumarate Ciprokiren HY-P10933